Mon Mar 7 Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash Written by PR Newswire Asia - News Pronto RSS Share to wechat： watch?v=N6QA6gDw_esRead more https://www.prnasia.com/story/archive/3675816_AE75816_0
